Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG.

Diabetes Care. 2010 Jul;33(7):1443-8. doi: 10.2337/dc09-2297. Epub 2010 Mar 31.

PMID:
20357369
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.

Diabet Med. 2006 Aug;23(8):920-3.

PMID:
16911633
[PubMed - indexed for MEDLINE]
3.

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.

Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P; IMDIAB Group.

Diabetes Care. 2010 Sep;33(9):1962-3. doi: 10.2337/dc10-0814.

PMID:
20805274
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).

Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z.

Diabetes Metab Res Rev. 2009 Jul;25(5):411-6. doi: 10.1002/dmrr.977.

PMID:
19488999
[PubMed - indexed for MEDLINE]
5.

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.

Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, Sütö G, Battelino T, Hosszufalusi N, Jermendy G.

Diabetes Metab Res Rev. 2007 May;23(4):276-85.

PMID:
17103487
[PubMed - indexed for MEDLINE]
6.

No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.

Walter M, Philotheou A, Bonnici F, Ziegler AG, Jimenez R; NBI-6024 Study Group.

Diabetes Care. 2009 Nov;32(11):2036-40. doi: 10.2337/dc09-0449. Epub 2009 Aug 18.

PMID:
19690081
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.

Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD.

Diabetes Care. 2008 Oct;31(10):1927-32. doi: 10.2337/dc08-0075. Epub 2008 Jun 12.

PMID:
18556343
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.

Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.

Diabetes Metab. 2010 Feb;36(1):64-70. doi: 10.1016/j.diabet.2009.07.004. Epub 2010 Jan 8.

PMID:
20060765
[PubMed - indexed for MEDLINE]
Free Article
9.

Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control.

Radtke MA, Nermoen I, Kollind M, Skeie S, Sørheim JI, Svartberg J, Hals I, Moen T, Dørflinger GH, Grill V.

Diabetes Care. 2010 Mar;33(3):589-94. doi: 10.2337/dc09-1436. Epub 2009 Dec 22.

PMID:
20028939
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.

Rother KI, Brown RJ, Morales MM, Wright E, Duan Z, Campbell C, Hardin DS, Popovic J, McEvoy RC, Harlan DM, Orlander PR, Brod SA.

Diabetes Care. 2009 Jul;32(7):1250-5. doi: 10.2337/dc08-2029. Erratum in: Diabetes Care. 2009 Sep;32(9):1751.

PMID:
19564474
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

Lancet. 2008 May 24;371(9626):1753-60. doi: 10.1016/S0140-6736(08)60762-X.

PMID:
18502299
[PubMed - indexed for MEDLINE]
12.

Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.

Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D.

Diabetes Metab Res Rev. 2007 May;23(4):292-8.

PMID:
17124720
[PubMed - indexed for MEDLINE]
13.

Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes.

Napoli N, Strollo R, Pitocco D, Bizzarri C, Maddaloni E, Maggi D, Manfrini S, Schwartz A, Pozzilli P; IMDIAB Group.

PLoS One. 2013;8(2):e56488. doi: 10.1371/journal.pone.0056488. Epub 2013 Feb 20.

PMID:
23437144
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.

Li J, Tian H, Li Q, Wang N, Wu T, Liu Y, Ni Z, Yu H, Liang J, Luo R, Li Y, Huang L.

Diabetes Obes Metab. 2007 Jul;9(4):558-65.

PMID:
17587398
[PubMed - indexed for MEDLINE]
15.

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

Horm Metab Res. 2006 Oct;38(10):668-72.

PMID:
17075776
[PubMed - indexed for MEDLINE]
16.

Preservation of beta cell function.

Sperling MA.

Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x. No abstract available.

PMID:
20546532
[PubMed - indexed for MEDLINE]
17.

Beta-cell protection and therapy for latent autoimmune diabetes in adults.

Cernea S, Buzzetti R, Pozzilli P.

Diabetes Care. 2009 Nov;32 Suppl 2:S246-52. doi: 10.2337/dc09-S317. Review. No abstract available.

PMID:
19875559
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L.

N Engl J Med. 2005 Jun 23;352(25):2598-608.

PMID:
15972866
[PubMed - indexed for MEDLINE]
Free Article
19.

Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients.

Bonakdaran S, Ayatollahi H, Mojahedi MJ, Sharifipoor F, Shakeri M.

Saudi J Kidney Dis Transpl. 2008 Nov;19(6):942-7.

PMID:
18974581
[PubMed - indexed for MEDLINE]
Free Article
20.

[C-peptide residual secretion makes difference on type 1 diabetes management?].

Rodacki M, Milech A, Oliveira JE.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):322-33. Review. Portuguese.

PMID:
18438543
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk